# Cannabis Use Linked to Reduced Opioid Use Among People Managing Withdrawal, Study Finds > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-use-linked-to-reduced-opioid-use-among-people-managing-withdrawal-study-finds/ > **Published:** 2026-06-25T23:08:46-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:50:35-04:00 > **Clinical Summary:** New study links cannabis opioid withdrawal symptom relief to reduced concurrent use. Clinical evidence gaps and what clinicians should know. --- ✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchPainAnxiety[Mental Health](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/)SafetyPolicyDosing Why This Matters Clinicians managing patients with opioid use disorder need to understand that cannabis may reduce withdrawal symptoms and opioid cravings, potentially offering a [harm reduction](https://cedclinic.com/can-you-mix-weed-and-alcohol/) strategy when pharmaceutical treatments are unavailable or inadequate. This finding could inform clinical conversations about medication-assisted treatment options and help providers recognize [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in this population as potentially therapeutic rather than purely problematic. However, clinicians should consider cannabis’s own dependence potential and need evidence on long-term outcomes before routinely recommending it as an opioid [withdrawal management](https://cedclinic.com/kratom-clinical-oversight-rising-cases-safety-concerns/) tool. Clinical Summary A new study in the Journal of [Cannabis Research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) demonstrates that [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) is associated with reduced opioid consumption among individuals managing opioid withdrawal symptoms, suggesting a potential [harm reduction](https://cedclinic.com/can-you-mix-weed-and-alcohol/) role for cannabis in the opioid crisis. The findings indicate that patients self-selecting cannabis for [withdrawal management](https://cedclinic.com/kratom-clinical-oversight-rising-cases-safety-concerns/) reported lower ongoing opioid use compared to those not using cannabis, though the observational design limits causal inference. This association is clinically relevant given the limited pharmacological options for alleviating withdrawal discomfort and the risk of relapse when patients return to opioids for symptom relief. However, clinicians should note that cannabis is not an FDA-approved treatment for opioid withdrawal, and evidence remains preliminary regarding efficacy, optimal dosing, and safety in this population. The potential for cannabis to reduce withdrawal symptom severity and opioid use warrants further investigation through rigorous randomized controlled trials before any clinical recommendations can be made. Clinicians caring for patients with opioid use disorder should be aware of this emerging evidence while maintaining established evidence-based [withdrawal management](https://cedclinic.com/kratom-clinical-oversight-rising-cases-safety-concerns/) protocols and considering [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in the context of overall treatment goals and local regulations. Dr. Caplan’s Take “The early signals here are worth watching, and I understand why patients might be drawn to this possibility, but we need to be careful about the directionality of the finding and whether cannabis is actually reducing opioid use or simply correlating with it—we need rigorous controlled trials in humans before we can counsel patients that this is a validated withdrawal strategy.” Clinical Perspective 💊 While this observational finding that cannabis use correlates with reduced opioid consumption during withdrawal is intriguing, clinicians should interpret it cautiously given the lack of mechanistic data and the inherent confounding in self-selected cannabis use patterns. The study does not establish whether cannabis genuinely alleviates withdrawal symptoms through a pharmacological mechanism, whether motivated individuals simply substitute one substance for another, or whether selection bias (patients who can access and use cannabis differ systematically from those who cannot) explains the association. Current evidence for cannabis as a withdrawal management tool remains limited compared to established pharmacotherapies like buprenorphine or clonidine, which have robust safety and efficacy data. In practice, while some patients may report subjective symptom relief with cannabis, clinicians should continue to prioritize evidence-based medication-assisted treatment and counseling as first-line approaches, and view cannabis use during withdrawal as a potential harm-reduction consideration rather 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Cannabis%20Use%20Linked%20to%20Reduced%20Opioid%20Use%20Among%20People%20Managing%20Withdrawal%2C%20Study%20Finds%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D66777)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D66777)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Cannabis%20Use%20Linked%20to%20Reduced%20Opioid%20Use%20Among%20People%20Managing%20Withdrawal%2C%20Study%20Finds%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D66777)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [French Medical Cannabis Experiment Yields “Positive” Effects](https://cedclinic.com/french-medical-cannabis-experiment-yields-positive-effects/) - Study links commercial cannabis markets to increased addiction – News-Medical.Net - [In the Mix: 39 More Articles — June 16, 2026](https://cedclinic.com/39-cannabis-articles-clinical-relevance-june-16-2026/) 📰 Source: [https://themarijuanaherald.com/2026/06/cannabis-use-linked-to-reduced-opioid-use-among-people-managing-withdrawal-study-finds/](https://themarijuanaherald.com/2026/06/cannabis-use-linked-to-reduced-opioid-use-among-people-managing-withdrawal-study-finds/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).